2023上半年营收增长0.7%,营业利润萎缩17.7%,净利润大幅萎缩72.2%。
目前市盈率17.6,市盈率TTM提高...查看全文
药明康德2019-12-04 12:17
▎医药观澜/报道
12月2日,知名网站GEN发布《2019全球免疫肿瘤学初创公司TOP10》,其中包括未上市的癌症免疫疗法企业,该排名按照企业总募资金额进行排名。值得一提的是,天境生物则以3.798亿美元募资额,成为唯一一家上榜的中国免疫肿瘤学初创公司。我们一起来看看,在即将过去的这一年,这1...查看全文
$SITE Centers(SITC)$ 内部交易: 2020-03-18,总裁 & CEO,Lukes David R ,买入,80000普通股, $5.52
$SITE Centers(SITC)$ 内部交易: 2020-03-19,EVP, CFO & Treasurer,Fennerty Conor ,买入,11000普通股, $4.58
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-020347 Size: 5 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-020290 Size: 5 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-015088 Size: 4 KB 网页链接
$SITE Centers(SITC)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-015093 Size: 6 KB 网页链接
$SITE Centers(SITC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-20-007127 Act: 34 Size: 34 MB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-012075 Size: 7 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-012062 Size: 4 KB 网页链接